Octagon-Capital-Advisors-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "MRUS",
  "TRVI",
  "CNTA",
  "APLS",
  "ABVX",
  "AVBP",
  "CATX",
  "TSHA",
  "TRML",
  "NUVB",
  "MNMD",
  "PHVS",
  "SNDX",
  "NGNE",
  "SRRK",
  null,
  "KALV",
  null,
  "UNCY",
  null,
  "ATYR",
  "SPRY",
  "RGLS",
  "MLTX",
  "COGT",
  "GOSS",
  "ERAS",
  "KLRS",
  "VRNA",
  "VSTM",
  "VRDN",
  "CRBP",
  "DNTH"
]

Filing Details

13F-HR/A • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-16
Total Holdings: 34
Total Value: 508167482
Accession Number: 0001839435-25-000005
Form Type: 13F-HR/A
CIK: octagon-capital-advisors-lp
Manager Name: Octagon-Capital-Advisors-Lp

Data Enrichment

91% identified

31 identified3 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

34 positions • $508.2M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

Scholar Rock Holding Corp

SRRK|80706P103

Shares:329.0K

Value:$10.6M

% of Portfolio:2.1% ($10.6M/$508.2M)

Verastem, Inc.

VSTM|92337C203

Shares:1.7M

Value:$10.4M

% of Portfolio:2.0% ($10.4M/$508.2M)

Regulus Therapeutics Inc.

RGLS|75915K309

Shares:4.6M

Value:$8.1M

% of Portfolio:1.6% ($8.1M/$508.2M)

ARS Pharmaceuticals, Inc.

SPRY|82835W108

Shares:625.0K

Value:$7.9M

% of Portfolio:1.5% ($7.9M/$508.2M)

Abivax S.A.

ABVX|00370M103

Shares:1.2M

Value:$7.7M

% of Portfolio:1.5% ($7.7M/$508.2M)

Erasca, Inc.

ERAS|29479A108

Shares:5.1M

Value:$7.0M

% of Portfolio:1.4% ($7.0M/$508.2M)

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:450.0K

Value:$6.1M

% of Portfolio:1.2% ($6.1M/$508.2M)

Corbus Pharmaceuticals Holdings, Inc.

CRBP|21833P301

Shares:1.1M

Value:$5.9M

% of Portfolio:1.2% ($5.9M/$508.2M)

Unicycive Therapeutics, Inc.

UNCY|90466Y103

Shares:10.0M

Value:$5.7M

% of Portfolio:1.1% ($5.7M/$508.2M)

578784100

Shares:468.0K

Value:$5.2M

% of Portfolio:1.0% ($5.2M/$508.2M)

Perspective Therapeutics, Inc.

CATX|46489V302

Shares:2.3M

Value:$4.8M

% of Portfolio:0.9% ($4.8M/$508.2M)

Kalaris Therapeutics, Inc.

KLRS|482929106

Shares:481.0K

Value:$3.9M

% of Portfolio:0.8% ($3.9M/$508.2M)

Neurogene Inc.

NGNE|64135M105

Shares:303.0K

Value:$3.5M

% of Portfolio:0.7% ($3.5M/$508.2M)

G4444H101

Shares:250.0K

Value:$2.8M

% of Portfolio:0.6% ($2.8M/$508.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Scholar Rock Holding Corp(SRRKcusip80706P103)	329.0K	QoQ -32.58% (-159.0K) YoY NEW(+329.0K)	All Managers (Combined)	$10.6M	2.1% ($10.6M/$508.2M)	QoQ -49.84% (-$10.5M) YoY NEW(+$10.6M)
Verastem, Inc.(VSTMcusip92337C203)	1.7M	QoQ NEW(+1.7M) YoY NEW(+1.7M)	All Managers (Combined)	$10.4M	2.0% ($10.4M/$508.2M)	QoQ NEW(+$10.4M) YoY NEW(+$10.4M)
Regulus Therapeutics Inc.(RGLScusip75915K309)	4.6M	QoQ -4.36% (-211.7K) YoY NEW(+4.6M)	All Managers (Combined)	$8.1M	1.6% ($8.1M/$508.2M)	QoQ +5.92% (-$453.8K) YoY NEW(+$8.1M)
ARS Pharmaceuticals, Inc.(SPRYcusip82835W108)	625.0K	QoQ NEW(+625.0K) YoY NEW(+625.0K)	All Managers (Combined)	$7.9M	1.5% ($7.9M/$508.2M)	QoQ NEW(+$7.9M) YoY NEW(+$7.9M)
Abivax S.A.(ABVXcusip00370M103)	1.2M	QoQ NEW(+1.2M) YoY NEW(+1.2M)	All Managers (Combined)	$7.7M	1.5% ($7.7M/$508.2M)	QoQ NEW(+$7.7M) YoY NEW(+$7.7M)
Erasca, Inc.(ERAScusip29479A108)	5.1M	QoQ 0.00% (-0) YoY NEW(+5.1M)	All Managers (Combined)	$7.0M	1.4% ($7.0M/$508.2M)	QoQ -45.41% (-$5.9M) YoY NEW(+$7.0M)
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	450.0K	QoQ -48.27% (-420.0K) YoY -27.41% (-170.0K)	All Managers (Combined)	$6.1M	1.2% ($6.1M/$508.2M)	QoQ -63.62% (-$10.6M) YoY -44.12% (-$4.8M)
Corbus Pharmaceuticals Holdings, Inc.(CRBPcusip21833P301)	1.1M	QoQ 0.00% (-0) YoY +175.30% (-710.0K)	All Managers (Combined)	$5.9M	1.2% ($5.9M/$508.2M)	QoQ -55.00% (-$7.2M) YoY -62.74% (-$10.0M)
Unicycive Therapeutics, Inc.(UNCYcusip90466Y103)	10.0M	QoQ 0.00% (-0) YoY NEW(+10.0M)	All Managers (Combined)	$5.7M	1.1% ($5.7M/$508.2M)	QoQ -27.61% (-$2.2M) YoY NEW(+$5.7M)
(cusip578784100)✕	468.0K	QoQ NEW(+468.0K) YoY NEW(+468.0K)	All Managers (Combined)	$5.2M	1.0% ($5.2M/$508.2M)	QoQ NEW(+$5.2M) YoY NEW(+$5.2M)
Perspective Therapeutics, Inc.(CATXcusip46489V302)	2.3M	QoQ -2.37% (-54.8K) YoY NEW(+2.3M)	All Managers (Combined)	$4.8M	0.9% ($4.8M/$508.2M)	QoQ -34.81% (-$2.6M) YoY NEW(+$4.8M)
Kalaris Therapeutics, Inc.(KLRScusip482929106)	481.0K	QoQ NEW(+481.0K) YoY NEW(+481.0K)	All Managers (Combined)	$3.9M	0.8% ($3.9M/$508.2M)	QoQ NEW(+$3.9M) YoY NEW(+$3.9M)
Neurogene Inc.(NGNEcusip64135M105)	303.0K	QoQ 0.00% (-0) YoY NEW(+303.0K)	All Managers (Combined)	$3.5M	0.7% ($3.5M/$508.2M)	QoQ -48.77% (-$3.4M) YoY NEW(+$3.5M)
(cusipG4444H101)✕	250.0K	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$2.8M	0.6% ($2.8M/$508.2M)	QoQ +7.61% (+$200.0K) YoY +9.17% (+$237.5K)